December 28, 2025 02:33 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
CBI moves Supreme Court challenging Kuldeep Sengar's relief in Unnao rape case | Music under attack: Islamist mob attacks James concert with bricks, stones in Bangladesh, dozens hurt | Christmas vandalism sparks mass arrests in Raipur; Assam acts too with crackdown on 'religious intolerance' | BJP's VV Rajesh becomes Thiruvananthapuram Mayor after party topples Left's 45-year-rule in city corporation | ‘I can’t bear the pain’: Indian-origin father of three dies after 8-hour hospital wait in Canada hospital | Janhvi Kapoor, Kajal Aggarwal, Jaya Prada slam brutal lynching in Bangladesh, call out ‘selective outrage’ | Tarique Rahman returns to Bangladesh after 17 years | Shocking killing inside AMU campus: teacher shot dead during evening walk | Horror on Karnataka highway: sleeper bus bursts into flames after truck crash, 9 killed | PM Modi attends Christmas service at Delhi church, sends message of love and compassion
Covid-19
NDMC worker sanitises Indian Parliament (Image Credit: UNI)

India adds close to 98,000 Covid-19 cases in 24 hours, tally crosses 51-lakh mark

| @indiablooms | Sep 17, 2020, at 04:10 pm

New Delhi/IBNS: The total number of Novel Coronavirus cases in India on Thursday crossed the 51-lakh mark as the country of 1.3 billion people reported a record spike in Covid-19 cases by adding 97,894 fresh infections in the last 24 hours.

With the new cases, India's Covid-19 tally has touched 51,18,253.

83,198 Covid-19 patients have so far succumbed to the virus with 1,132 people dying from the disease in the last 24 hours.

Meanwhile, the Serum Institute of India (SII) has got the nod of the Drug Controller General of India (DCGI) to resume the phase two and three trials for Covid-19 vaccine, which has been developed by pharmaceutical giant AstraZeneca and Oxford University.

The Oxford vaccine trial was first halted by AstraZeneca after a suspected serious adverse reaction was seen in a participant in the United Kingdom last week.

Following the development, the SII had also halted the vaccine trials in the country.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.